Razor Labs(IL:RZR)
ILAÂ 594.50+9.50 (+1.62%)
IL:RZR
Razor Labs financials statements
ILAÂ 594.50
At close:+9.50 (+1.62%)
Want to see IL:RZR full AI Analyst Report?
Razor Labs (RZR) Ratios
1 Followers
Razor Labs Ratios
IL:RZR's free cash flow for Q2 2026 was ₪3.07M. For the 2026 fiscal year, IL:RZR's free cash flow was decreased by ₪-77.50K and operating cash flow was ₪3.15M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.58 | 1.88 | 3.43 | 6.97 | 7.86 |
| Quick Ratio | 1.46 | 1.88 | 3.43 | 6.97 | 7.86 |
| Cash Ratio | 1.25 | 1.72 | 2.88 | 6.63 | 2.96 |
| Solvency Ratio | -0.24 | -0.18 | -0.26 | -0.86 | -1.24 |
| Operating Cash Flow Ratio | -0.60 | -0.01 | 0.97 | -3.55 | -3.34 |
| Short-Term Operating Cash Flow Coverage | -7.72 | 0.00 | 0.00 | -9.18 | -96.71 |
| Net Current Asset Value | ₪ -10.22M | ₪ -8.14M | ₪ 3.90M | ₪ 18.33M | ₪ 45.86M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.23 | 0.25 | 0.33 | 0.22 |
| Debt-to-Equity Ratio | -2.06 | 1.64 | 0.81 | 0.54 | 0.33 |
| Debt-to-Capital Ratio | 1.94 | 0.62 | 0.45 | 0.35 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -17.24 | 7.17 | 3.24 | 1.67 | 1.45 |
| Debt Service Coverage Ratio | -3.94 | -8.34 | -10.48 | -6.43 | -24.05 |
| Interest Coverage Ratio | -15.04 | -13.09 | -13.66 | -26.12 | -35.28 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.10 | 0.00 |
| Interest Debt Per Share | 0.18 | 0.50 | 0.56 | 0.62 | 0.63 |
| Net Debt to EBITDA | 2.26 | 3.42 | 2.24 | 0.91 | 0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.45% | 41.49% | 12.25% | 31.21% | 13.44% |
| EBIT Margin | -47.76% | -82.37% | -323.01% | -514.64% | -275.40% |
| EBITDA Margin | -37.21% | -62.80% | -259.13% | -453.37% | -256.71% |
| Operating Profit Margin | -47.76% | -99.03% | -338.26% | -532.34% | -305.13% |
| Pretax Profit Margin | -48.62% | -89.59% | -347.77% | -533.97% | -284.05% |
| Net Profit Margin | -48.79% | -89.90% | -346.61% | -535.91% | -292.79% |
| Continuous Operations Profit Margin | -48.80% | -89.91% | -348.05% | -535.91% | -292.79% |
| Net Income Per EBT | 100.34% | 100.34% | 99.67% | 100.36% | 103.08% |
| EBT Per EBIT | 101.81% | 90.47% | 102.81% | 100.31% | 93.09% |
| Return on Assets (ROA) | -32.68% | -19.37% | -22.13% | -38.66% | -41.07% |
| Return on Equity (ROE) | 563.41% | -138.92% | -71.70% | -64.39% | -59.49% |
| Return on Capital Employed (ROCE) | -70.19% | -35.75% | -27.51% | -42.39% | -47.40% |
| Return on Invested Capital (ROIC) | -64.23% | -33.13% | -26.05% | -39.24% | -46.10% |
| Return on Tangible Assets | -32.68% | -19.37% | -22.13% | -38.66% | -41.07% |
| Earnings Yield | -7.34% | -7.15% | -28.21% | -104.80% | -28.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.90 | 5.35 | 3.54 | 3.36 | 5.56 |
| Payables Turnover | 5.59 | 3.25 | 4.14 | 5.93 | 9.13 |
| Inventory Turnover | 6.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 7.14 | 0.96 | 0.26 | 0.22 | 0.62 |
| Asset Turnover | 0.67 | 0.22 | 0.06 | 0.07 | 0.14 |
| Working Capital Turnover Ratio | 1.55 | 0.48 | 0.13 | 0.10 | 0.41 |
| Cash Conversion Cycle | 36.51 | -44.19 | 14.86 | 46.99 | 25.71 |
| Days of Sales Outstanding | 46.23 | 68.23 | 103.12 | 108.58 | 65.68 |
| Days of Inventory Outstanding | 55.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 65.25 | 112.43 | 88.26 | 61.59 | 39.97 |
| Operating Cycle | 101.76 | 68.23 | 103.12 | 108.58 | 65.68 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.43 | -0.01 | 0.44 | -0.61 | -0.86 |
| Free Cash Flow Per Share | -0.43 | -0.01 | 0.44 | -0.61 | -0.95 |
| Dividend Paid and CapEx Coverage Ratio | -101.82 | -1.19 | 118.18 | -162.16 | -8.99 |
| Capital Expenditure Coverage Ratio | -101.82 | -1.19 | 118.18 | -162.16 | -8.99 |
| Operating Cash Flow Coverage Ratio | -2.74 | -0.02 | 0.83 | -1.03 | -1.44 |
| Operating Cash Flow to Sales Ratio | -0.49 | -0.02 | 3.26 | -4.63 | -2.31 |
| Free Cash Flow Yield | -7.42% | -0.26% | 26.33% | -91.20% | -24.65% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -13.60 | -14.21 | -3.54 | -0.95 | -3.56 |
| Price-to-Sales (P/S) Ratio | 6.65 | 12.57 | 12.29 | 5.11 | 10.41 |
| Price-to-Book (P/B) Ratio | -76.77 | 19.42 | 2.54 | 0.61 | 2.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.48 | -381.66 | 3.80 | -1.10 | -4.06 |
| Price-to-Operating Cash Flow Ratio | -13.62 | -702.60 | 3.77 | -1.10 | -4.51 |
| Price-to-Earnings Growth (PEG) Ratio | -1.33 | 0.83 | 0.11 | 0.03 | -0.00 |
| Enterprise Value Multiple | -15.61 | -16.59 | -2.50 | -0.22 | -3.88 |
| Enterprise Value | 201.10M | 179.39M | 34.30M | 5.02M | 141.41M |
| EV to EBITDA | -15.61 | -16.59 | -2.50 | -0.22 | -3.88 |
| EV to Sales | 5.81 | 10.42 | 6.49 | 0.98 | 9.96 |
| EV to Free Cash Flow | -11.78 | -316.38 | 2.01 | -0.21 | -3.88 |
| EV to Operating Cash Flow | -11.90 | -582.43 | 1.99 | -0.21 | -4.31 |
| Tangible Book Value Per Share | -0.08 | 0.29 | 0.66 | 1.09 | 1.83 |
| Shareholders’ Equity Per Share | -0.08 | 0.29 | 0.66 | 1.09 | 1.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.03 |
| Revenue Per Share | 0.88 | 0.44 | 0.14 | 0.13 | 0.37 |
| Net Income Per Share | -0.43 | -0.40 | -0.47 | -0.70 | -1.09 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.03 |
| Interest Burden | 1.02 | 1.09 | 1.08 | 1.04 | 1.03 |
| Research & Development to Revenue | 0.47 | 0.72 | 1.78 | 3.14 | 1.30 |
| SG&A to Revenue | 0.38 | 0.24 | 0.32 | 0.49 | 0.24 |
| Stock-Based Compensation to Revenue | 0.02 | 0.06 | 0.13 | 0.07 | 0.52 |
| Income Quality | 1.00 | 0.02 | -0.94 | 0.86 | 0.79 |
Currency in ILS
